Acadia Healthcare (NASDAQ:ACHC) Stock Price Up 2.9% – Still a Buy?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) was up 2.9% on Monday . The company traded as high as $54.15 and last traded at $53.55. Approximately 763,777 shares changed hands during mid-day trading, a decline of 18% from the average daily volume of 931,295 shares. The stock had previously closed at $52.03.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on ACHC shares. Deutsche Bank Aktiengesellschaft upped their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Friday, September 20th. Barclays reduced their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a research note on Monday, September 30th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 target price on shares of Acadia Healthcare in a research note on Tuesday, October 1st. Finally, KeyCorp started coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a “sector weight” rating for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Stock Performance

The stock has a market capitalization of $4.71 billion, a P/E ratio of -362.29, a PEG ratio of 1.57 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The company’s fifty day simple moving average is $69.95 and its two-hundred day simple moving average is $69.14.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.87 by $0.04. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm had revenue of $796.00 million for the quarter, compared to analysts’ expectations of $784.38 million. During the same period in the prior year, the firm earned $0.92 EPS. The business’s revenue was up 8.8% on a year-over-year basis. As a group, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.51 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in ACHC. Point72 Asset Management L.P. increased its holdings in shares of Acadia Healthcare by 266.0% during the second quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the period. Millennium Management LLC boosted its position in shares of Acadia Healthcare by 3,067.8% during the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after acquiring an additional 1,055,894 shares in the last quarter. William Blair Investment Management LLC boosted its position in shares of Acadia Healthcare by 20.7% during the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after acquiring an additional 604,070 shares in the last quarter. Vaughan Nelson Investment Management L.P. boosted its position in shares of Acadia Healthcare by 67.9% during the 2nd quarter. Vaughan Nelson Investment Management L.P. now owns 733,505 shares of the company’s stock worth $49,541,000 after acquiring an additional 296,625 shares in the last quarter. Finally, Clearline Capital LP acquired a new stake in shares of Acadia Healthcare during the 2nd quarter worth approximately $11,179,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.